Coordinating steps to a Cancer Moonshot
164693
post-template-default,single,single-post,postid-164693,single-format-standard,bridge-core-1.0.5,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.1,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-6.0.2,vc_responsive
 

Coordinating steps to a Cancer Moonshot

Coordinating steps to a Cancer Moonshot

By Kevin Conroy, Medium

kevin_conroy2When President Nixon signed the National Cancer Act, the goal was clear: a national commitment to cure cancer. And while major progress has been made during the last half century, cancer remains a leading cause of death. That’s why the Administration’s new national effort — the Cancer Moonshot — has left many wondering if significant progress is realistic.

The Cancer Moonshot goal of making a decade’s worth of progress in cancer prevention, diagnosis, treatment and care in five years is both audacious and achievable.

The Cancer Moonshot goal of making a decade’s worth of progress in cancer prevention, diagnosis, treatment and care in five years is both audacious and achievable. As the leader of a biotech company that earned FDA approval for an at-home colon cancer screening test, I have seen firsthand how innovation and collaboration among the private sector, government, and research institutions can make a real difference in bringing lifesaving screening tools to market — quickly.

As Vice President Biden said at last week’s Cancer Moonshot Summit, “Prevention can help save a lot more lives than anything else we can do.” This is why expanding access to innovative screening tools is imperative to reaching the Moonshot goal. Read more …

Kevin Conroy is Chairman, President and CEO of Exact Sciences Corp., the Madison-Wisconsin based developer and manufacturer of Cologuard.